Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
José Manuel Cóndor Capcha, Guerline Lambert, Derek M. Dykxhoorn, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
Damir Bojadzic, Óscar Garnica, Jinshui Chen, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 6, pp. 1519-1534
Open Access | Times Cited: 120
Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs
Antoine Rebendenne, Priyanka Roy, Boris Bonaventure, et al.
Nature Genetics (2022) Vol. 54, Iss. 8, pp. 1090-1102
Open Access | Times Cited: 97
SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3
Utkarsh Tripathi, Rayhane Nchioua, Larissa Prata, et al.
Aging (2021) Vol. 13, Iss. 18, pp. 21838-21854
Open Access | Times Cited: 68
Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies
Niko Kohmer, Cornelia Rühl, Sandra Ciesek, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 10, pp. 2128-2128
Open Access | Times Cited: 60
APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients
Hongsheng Zhang, Lin Shao, Zhihao Lin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 44
Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
Kuan‐Ting Liu, Yi-Ju Han, Guan-Hong Wu, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1560-1560
Open Access | Times Cited: 39
Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives
Tao Dong, Mingyang Wang, Junchong Liu, et al.
Chemical Science (2023) Vol. 14, Iss. 23, pp. 6149-6206
Open Access | Times Cited: 35
A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection
Pehuén Pereyra Gerber, Lidia M. Duncan, Edward JD Greenwood, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010265-e1010265
Open Access | Times Cited: 34
Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies
Pia Gattinger, Anna Ohradanova‐Repic, Rudolf Valenta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5352-5352
Open Access | Times Cited: 19
SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells
Ik-Jung Kim, Yong‐ho Lee, Mir M. Khalid, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 8, pp. 104955-104955
Open Access | Times Cited: 16
Variant-specific interactions at the plasma membrane: Heparan sulfate’s impact on SARS-CoV-2 binding kinetics
Dario Valter Conca, Fouzia Bano, Julius von Wirén, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Immune response against SARS-CoV-2 variants: the role of neutralization assays
Alicja Chmielewska, Anna Czarnota, Krystyna Bieńkowska-Szewczyk, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 34
Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019
Marcela Salazar–García, Samyr Acosta-Contreras, Griselda Rodríguez‐Martínez, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 25
Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
Judith Grau-Expósito, David Perea, Marina Suppi, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 1, pp. e1010171-e1010171
Open Access | Times Cited: 24
Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
Hadeel T. Zedan, Hadi M. Yassine, Duaa W. Al‐Sadeq, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Melanie Engler, Dan Albers, Pascal von Maltitz, et al.
Life Science Alliance (2023) Vol. 6, Iss. 9, pp. e202201880-e202201880
Open Access | Times Cited: 13
Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing
Joseph Andrew Whitley, Houjian Cai
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 9
Open Access | Times Cited: 12
Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses
Syamala Rani Thimmiraju, Jason T. Kimata, Jeroen Pollet
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 174-185
Open Access | Times Cited: 4
SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review
Yeqing Sun, Weijin Huang, Hongyu Xiang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 554-554
Open Access | Times Cited: 4
GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus
Hsin Yeh, Di Ngoc Kha Vo, Zhi‐Hu Lin, et al.
Phytomedicine (2022) Vol. 103, pp. 154215-154215
Open Access | Times Cited: 18
LRRC15 inhibits SARS-CoV-2 cellular entry in trans
Jaewon Song, Ryan D. Chow, Mario A. Peña-Hernández, et al.
PLoS Biology (2022) Vol. 20, Iss. 10, pp. e3001805-e3001805
Open Access | Times Cited: 18
Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination
Heather N. Grome, Michael G. Threlkeld, Steve Threlkeld, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 11, pp. 2914-2918
Open Access | Times Cited: 23
Neutralizing antibody activity against SARS-CoV-2 variants in gestational age–matched mother-infant dyads after infection or vaccination
Yusuke Matsui, Lin Li, Mary Prahl, et al.
JCI Insight (2022) Vol. 7, Iss. 12
Open Access | Times Cited: 17
Covalent coupling of Spike’s receptor binding domain to a multimeric carrier produces a high immune response against SARS-CoV-2
Paula M. Berguer, Matı́as Blaustein, Luis M. Bredeston, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 16
SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes
Raj Kalkeri, Zhaohui Cai, Shuling Lin, et al.
Microorganisms (2021) Vol. 9, Iss. 8, pp. 1744-1744
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top